# Study to Evaluate the Safety and Efficacy of ARI0002h, for the Initial Treatment of Patients With Primary Plasma Cell Leukaemia

> **NCT06830733** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Fundacion Clinic per a la Recerca Biomédica** · enrollment: 25 (estimated)

## Conditions studied

- Leukemia, Plasma Cell

## Interventions

- **GENETIC:** ARI0002h

## Key facts

- **NCT ID:** NCT06830733
- **Lead sponsor:** Fundacion Clinic per a la Recerca Biomédica
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-04
- **Primary completion:** 2025-12
- **Final completion:** 2027-12
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2025-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06830733

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06830733, "Study to Evaluate the Safety and Efficacy of ARI0002h, for the Initial Treatment of Patients With Primary Plasma Cell Leukaemia". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT06830733. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*